OncoMatch/Clinical Trials/NCT06235151
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Is NCT06235151 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Copper Cu 64 PSMA I&T for prostate cancer.
Treatment: Copper Cu 64 PSMA I&T — This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate cancer.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Prostate Cancer
Demographics
Prior therapy
Cannot have received: androgen deprivation therapy
Androgen deprivation therapy...prior to prostatectomy
Cannot have received: neoadjuvant chemotherapy
neoadjuvant chemotherapy...prior to prostatectomy
Cannot have received: radiation therapy (including local ablation techniques)
radiation therapy (including local ablation techniques)...prior to prostatectomy
Cannot have received: investigational therapy
any investigational therapy against Prostate Cancer (PC) prior to prostatectomy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Arkansas Urology · Little Rock, Arkansas
- Providence Medical Foundation · Fullerton, California
- Tower Urology · Los Angeles, California
- VA Greater Los Angeles Healthcare System · Los Angeles, California
- Hoag Memorial Hospital Presbyterian · Newport Beach, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT06235151 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages